Involvement of ST6Gal i in the biosynthesis of a unique human colon cancer biomarker candidate, α2,6-sialylated blood group type 2H (ST2H) antigen

Journal of Biochemistry

Volumn 148, Issue 3, 2010, Pages 359-370

  Korekane, Hiroaki ^a   Matsumoto, Akio ^a,d   Ota, Fumi ^a   Hasegawa, Tomoko ^a   Misonou, Yoshiko ^b   Shida, Kyoko ^b   Miyamoto, Yasuhide ^b   Taniguchi, Naoyuki ^a,c  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c RIKEN   (Japan)

^d CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

1,2 fucosyltransferase; 2, 6 sialyltransferase; colon cancer; fucoganglioside; ST2H antigen

Indexed keywords

ALPHA1,2 FUCOSYLTRANSFERASES; ALPHA2,6 SIALYLTRANSFERASES; CYTIDINE PHOSPHATE N ACETYLNEURAMINIC ACID; ENZYME; ST2H ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BIOSYNTHESIS; CANCER CELL; COLON CANCER; ENZYME ACTIVITY; ENZYME PURIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; SCREENING TEST; SIALYLATION; UPREGULATION;

ANTIGENS, CD; ANTIGENS, NEOPLASM; BLOOD GROUP ANTIGENS; CELL LINE, TUMOR; COLONIC NEOPLASMS; FUCOSYLTRANSFERASES; HUMANS; KINETICS; SIALYLTRANSFERASES; SUBSTRATE SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77956439545     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvq077     Document Type: Article

References (37)

1. Varki, A. (1993) Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3, 97-130
2. Dwek, R.A. (1995) Glycobiology: towards understanding the function of sugars. Biochem. Soc. Trans. 23, 1-25
3. Dennis, J.W., Granovsky, M., and Warren, C.E. (1999) Protein glycosylation in development and disease. Bioessays 21, 412-421
4. Kobata, A. (2000) A journey to the world of glycobiology. Glycoconj. J. 17, 443-464
5. Dube, D.H. and Bertozzi, C.R. (2005) Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 4, 477-488
6. Hakomori, S. (1996) Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res. 56, 5309-5318
7. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc. Natl Acad. Sci. USA 99, 10231-10233
8. Hakomori, S., Nudelman, E., Levery, S.B., and Patterson, C.M. (1983) Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl alpha 2 leads to 6 galactosyl residue: a preliminary note. Biochem. Biophys. Res. Commun. 113, 791-798
9. Hakomori, S., Nudelman, E., Levery, S.B., and Kannagi, R. (1984) Novel fucolipids accumulating in human adenocarcinoma: I. Glycolipids with di- or trifucosylated type 2 chain. J. Biol. Chem. 259, 4672-4680
10. Fukushi, Y., Hakomori, S., Nudelman, E., and Cochran, N. (1984) Novel fucolipids accumulating in human adenocarcinoma. II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J. Biol. Chem. 259, 4681-4685
11. Fukushi, Y., Nudelman, E., Levery, S.B., Hakomori, S., and Rauvala, H. (1984) Novel fucolipids accumulating in human adenocarcinoma: III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J. Biol. Chem. 259, 10511-10517
12. Nudelman, E., Fukushi, Y., Levery, S.B., Higuchi, T., and Hakomori, S. (1986) Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (III4FucIII6NeuAcIV3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J. Biol. Chem. 261, 5487-5495
13. Nudelman, E., Levery, S.B., Kaizu, T., and Hakomori, S. (1986) Novel fucolipids of human adenocarcinoma: characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI2FucnLc6). J. Biol. Chem. 261, 11247-11253
14. Portoukalian, J., Zwingelstein, G., and Dore, J.F. (1979) Lipid composition of human malignant melanoma tumors at various levels of malignant growth. Eur. J. Biochem. 94, 19-23
15. Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., and Kimura, N. (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95, 377-384
16. Korekane, H., Tsuji, S., Noura, S., Ohue, M., Sasaki, Y., Imaoka, S., and Miyamoto, Y. (2007) Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis. Anal. Biochem. 364, 37-50
17. Misonou, Y., Shida, K., Korekane, H., Seki, Y., Noura, S., Ohue, M., and Miyamoto, Y. (2009) Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells. J. Proteome Res. 8, 2990-3005
18. Hamamoto, T. and Tsuji, S. (2002) ST6Gal-I in Handbook of Glycosyltransferases and Related Genes (Taniguchi, N., Honke, K., and Fukuda, M., eds), pp. 295-300, Springer, Tokyo
19. Takashima, S., Tsuji, S., and Tsujimoto, M. (2002) Characterization of the second type of human b-galactoside a2,6-sialyltransferase (ST6Gal II), which sialylates Galb1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes. J. Biol. Chem. 277, 45719-45728
20. Krzewinski-Recchi, M.A., Julien, S., Juliant, S., Teintenier-Lelievre, M., Samyn-Petit, B., Montiel, M.D., Mir, A.M., Cerutti, M., Harduin-Lepers, A., and Delannoy, P. (2003) Identification and functional expression of a second human b-galactoside a2,6- sialyltransferase, ST6Gal II. Eur. J. Biochem. 270, 950-961
21. Oriol, R. and Mollicone, R. (2002) a2-Fucosyltransferases (FUT1, FUT2, and Sec1) in Handbook of Glycosyltransferases and Related Genes (Taniguchi, N., Honke, K., and Fukuda, M., eds), pp. 205-217, Springer, Tokyo
22. Nakamura, M., Tsunoda, A., Yanagisawa, K., Furukawa, Y., Kikuchi, J., Iwase, S., Sakai, T., Larson, G., and Saito, M. (1997) CMP-NeuAc:Galb1 !4GlcNAc a2!6sialyltransferase catalyzes NeuAc transfer to glycolipids. J. Lipid Res. 38, 1795-1806
23. Iwamori, M., Tanaka, K., Kubushiro, K., Lin, B., Kiguchi, K., Ishiwata, I., Tsukazaki, K., and Nozawa, S. (2005) Alterations in the glycolipid composition and cellular properties of ovarian carcinoma-derived RMG-1 cells on transfection of the a1,2-fucosyltransferase gene. Cancer Sci. 96, 26-30
24. Kitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T.C., and Hashimoto, Y. (2001) Alzheimers b-secretase, b-site amyloid precursor protein-cleaving enzyme, is responsible for cleavage secretion of a Golgi-resident sialyltransferase. Proc. Natl Acad. Sci. USA 98, 13554-13559
25. Harvey, D.J., Mattu, T.S., Wormald, M.R., Royle, L., Dwek, R.A., and Rudd, P.M. (2002) Internal residue loss: rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus. Anal. Chem. 74, 734-740
26. Hidari, K.I., Horie, N., Murata, T., Miyamoto, D., Suzuki, T., Usui, T., and Suzuki, Y. (2005) Purification and characterization of a soluble recombinant human ST6Gal I functionally expressed in Escherichia coli. Glycoconj. J. 22, 1-11
27. DallOlio, F., Malagolini, N., di Stefano, G., Minni, F., Marrano, D., and Serafini-Cessi, F. (1989) Increased CMP-NeuAc:Galb1,4GlcNAc-R a2,6 sialyltransferase activity in human colorectal cancer tissues. Int. J. Cancer 44, 434-439
28. Gessner, P., Riedl, S., Quentmaier, A., and Kemmner, W. (1993) Enhanced activity of CMP-NeuAc:Galb1- 4GlcNAc:a2,6-sialyltransferase in metastasizing human colorectal tumor tissue and serum of tumor patients. Cancer Lett. 75, 143-149
29. Gangopadhyay, A., Perera, S.P., and Thomas, P. (1998) Differential expression of a2,6-sialyltransferase in colon tumors recognized by a monoclonal antibody. Hybridoma 17, 117-123
30. Kemmner, W., Roefzaad, C., Haensch, W., and Schlag, P.M. (2003) Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays. Biochim. Biophys. Acta 1621, 272-279
31. Petretti, T., Kemmner, W., Schulze, B., and Schlag, P.M. (2000) Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 46, 359-366
32. DallOlio, F., Chiricolo, M., Ceccarelli, C., Minni, F., Marrano, D., and Santini, D. (2000) b-galactoside a2,6 sialyltransferase in human colon cancer: contribution of multiple transcripts to regulation of enzyme activity and reactivity with Sambucus nigra agglutinin. Int. J. Cancer 88, 58-65
33. Hakomori, S., Patterson, C.M., Nudelman, E., and Sekiguchi, K. (1983) A monoclonal antibody directed to N-acetylneuraminosyl-a2 leads to 6-galactosyl residue in gangliosides and glycoproteins. J. Biol. Chem. 258, 11819-11822
34. Nilsson, O., Lindholm, L., Holmgren, J., and Svennerholm, L. (1985) Monoclonal antibodies raised against NeuAca2-6neolactotetraosylceramide detect carcinoma-associated gangliosides. Biochim. Biophys. Acta 835, 577-583
35. DallOlio, F. and Trere, D. (1993) Expression of a2, 6-sialylated sugar chains in normal and neoplastic colon tissues. Detection by digoxigenin- conjugated Sambucus nigra agglutinin. Eur. J. Histochem. 37, 257-265
36. Yamashita, K., Fukushima, K., Sakiyama, T., Murata, F., Kuroki, M., and Matsuoka, Y. (1995) Expression of Siaa2!6Galb1!4GlcNAc residues on sugar chains of glycoproteins including carcinoembryonic antigens in human colon adenocarcinoma: applications of Trichosanthes japonica agglutinin I for early diagnosis. Cancer Res. 55, 1675-1679
37. Sarnesto, A., Kö hlin, T., Hindsgaul, O., Thurin, J., and Blaszczyk-Thurin, M. (1992) Purification of the secretor-type b-galactoside a1!2-fucosyltransferase from human serum. J. Biol. Chem. 267, 2737-2744